Kopran Limited

BSE: 524280 NSE: KOPRAN
Kopran Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24230MH1958PLC011078 Incorporated 26 April 1958 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: KOPRAN · BSE: 524280 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹681.42 Cr
▲ 8.23% YoY
EBITDA · FY 2026
₹62.3 Cr
▼ 18.97% YoY
Net profit · FY 2026
₹25.73 Cr
▼ 33.26% YoY
Authorised capital
₹70 Cr
Registered with MCA
Paid-up capital
₹48.29 Cr
Issued & subscribed
Open charges
₹856.35 Cr
Satisfied ₹727.36 Cr
Company age
68 yrs
Est. 1958
Employees · EPFO
363
Latest available

About Kopran Limited

Data last updated: 22 December 2025

Kopran Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 26 April 1958, the company has been in operation for over 68 years.

Registered with ROC Mumbai under CIN L24230MH1958PLC011078. Listed on BSE: 524280 and NSE: KOPRAN.

Capital: an authorised share capital of ₹70 Cr and a paid-up capital of ₹48.29 Cr. Formerly known as Kopran Chemical Company Private Limited. It is led by directors including Chandresh Gunvant Gandhi and Surendra Somani.

Last AGM: 11 September 2024. Financial statements filed for year ended 31 March 2024. Office: Parijat House1076 Dr E Moses Road Worli Mumbai – 18, Maharashtra, India – 400018.

As per the financials filed for FY 2024, the company reported a revenue of ₹629.2 Cr, a growth of 14% compared to the previous year.

The company has a workforce of approximately 363 employees as per the latest available data. Its group structure includes 2 subsidiaries.

The company is associated with 1 brand - Kopran. As per MCA filings, the company has open charges of ₹856.35 Cr and satisfied charges of ₹727.36 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kopran.com.

Company Details of Kopran Limited
CIN L24230MH1958PLC011078
Registration Number 011078
Incorporation Date 26 April 1958
ROC Mumbai
Listing Status Listed (BSE: 524280, NSE: KOPRAN)
Company Status Active
Date of Last AGM 11 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Surendra Somani Managing Director Chandresh Gunvant Gandhi Additional Director Adarsh Rajendra Somani Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    kopran.com
  • Social Media
  • Registered Address
    Parijat House1076 Dr E Moses Road Worli Mumbai – 18, Maharashtra, India – 400018
  • Industry
    Pharma, Drug Formulation & Development
Company report
Kopran Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Kopran Limited report

Financials, compliance, directors, charges, ownership and filings for Kopran Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Kopran Limited

Kopran Limited operates one associated brand: Kopran. These brands represent Kopran Limited's diversified market presence and brand portfolio.

Brand Description Website
Kopran
Pharmaceutical Company manufacturing a range of products kopran.com

Competitors & Alternatives of Kopran Limited

Brands and companies operating in the same space as Kopran Limited include Concord Biotech, Almac Group, Indoco Remedies and 6 more.

Competitor Description Location Founded
Concord Biotech Concord Biotech APIs and enzymes are manufactured through fermentation by the CDMO. Ahmedabad, India, India 2000
Almac Group Almac Group Integrated CDMO services for biopharma R&D and manufacturing are offered. Craigavon, United Kingdom, United Kingdom 2001
Indoco Remedies Indoco Remedies APIs manufacturing and formulation services are provided in therapeutic segments. Mumbai, India, India 1947
Pharmaceutics International Pharmaceutics International Pharmaceutical dosage forms are manufactured by this CDMO. Hunt Valley, United States, United States 1994
Aurobindo Pharma Aurobindo Pharma Generic biocatalytic solutions are provided for pharmaceutical applications. Hyderabad, India, India 1986
Seqens Seqens Contract manufacturing services for small molecules and peptides are provided. Ecully, France, France 2003
Asymchem Asymchem APIs and peptides are developed and manufactured by Asymchem. Morrisville, United States, United States 1995
Aptuit Aptuit Contract research and development services for small molecules are offered. Greenwich, United States, United States 2004
Continuus Pharma Continuus Pharma MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development Woburn, United States, United States 2012

Business Activity of Kopran Limited

Kopran Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Kopran Limited

Kopran Limited is audited by Khandelwal Jain & Co (ICAI peer reviewed, certificate valid till 2028-08-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Khandelwal Jain & Co (ICAI peer reviewed, certificate valid till 2028-08-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Kopran Limited

Kopran Limited is currently managed by 8 directors, with 23 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Chandresh Gunvant Gandhi
Also directs: Control Print Limited
Additional Director 29 Jul 2025 0 Years 11 Months Current
Surendra Somani
Also directs: Kopran Lifesciences Limited
Managing Director 11 Jun 1997 29 Years 0 Months Current
Adarsh Rajendra Somani
Also directs: Oricon Enterprises Limited, G Claridge And Company Limited, Kopran Laboratories Limited and 5 more
Director 29 May 2018 8 Years 1 Months Current
Varun Surendra Somani
Also directs: Oricon Enterprises Limited, G Claridge And Company Limited, Kopran Laboratories Limited and 5 more
Director 29 May 2018 8 Years 1 Months Current
Mamta Ashok Biyani
Also directs: Oricon Enterprises Limited, United Shippers Limited, Image Commercials Llp and 3 more
Director 08 May 2019 7 Years 2 Months Current
Narayan Tulsiram Atal
Also directs: International Conveyors Limited, Taparia Tools Limited, Gama Leafin Private Limited and 4 more
Director 08 May 2019 7 Years 2 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Kopran Limited FY 2026 filings available

Kopran Limited reported revenue of ₹681.42 Cr (up 8.23% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹681.42 Cr ▲ 8.23%
Profit · FY 2026
₹25.73 Cr ▼ 33.26%
EBITDA · FY 2026
₹62.3 Cr ▼ 18.97%
Revenue₹ Cr · Consolidated0250500750FY 2020: ₹359 Cr359FY 2020FY 2021: ₹492 Cr · +36.8% YoY492+36.8%FY 2021FY 2022: ₹478 Cr · -2.9% YoY478-2.9%FY 2022FY 2023: ₹551 Cr · +15.4% YoY551+15.4%FY 2023FY 2024: ₹615 Cr · +11.5% YoY615+11.5%FY 2024FY 2025: ₹630 Cr · +2.4% YoY630+2.4%FY 2025FY 2026: ₹681 Cr · +8.2% YoY681+8.2%FY 2026
Net Profit₹ Cr · Consolidated0255075FY 2020: ₹21 Cr21FY 2020FY 2021: ₹62 Cr · +193.1% YoY61.6+193.1%FY 2021FY 2022: ₹61 Cr · -0.9% YoY61-0.9%FY 2022FY 2023: ₹27 Cr · -55.4% YoY27.2-55.4%FY 2023FY 2024: ₹51 Cr · +87.1% YoY51+87.1%FY 2024FY 2025: ₹39 Cr · -24.3% YoY38.6-24.3%FY 2025FY 2026: ₹26 Cr · -33.3% YoY25.7-33.3%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0100200300Q1'25: ₹139 Cr · +19.2% YoY139+19.2%Q1'25Q2'25: ₹152 Cr · -0.7% YoY152-0.7%Q2'25Q3'25: ₹166 Cr · +4.6% YoY166+4.6%Q3'25Q4'25: ₹172 Cr · -7.4% YoY172-7.4%Q4'25Q1'26: ₹135 Cr · -3% YoY135-3%Q1'26Q2'26: ₹118 Cr · -22.2% YoY118-22.2%Q2'26Q3'26: ₹194 Cr · +16.9% YoY194+16.9%Q3'26Q4'26: ₹234 Cr · +35.8% YoY234+35.8%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹681.42 Cr ₹629.6 Cr ₹614.59 Cr ₹550.99 Cr ₹477.52 Cr ₹491.81 Cr ₹359.5 Cr
Other Income ₹34.57 Lakh ₹3.98 Cr ₹14.61 Cr ₹3.07 Cr ₹10.6 Cr ₹17.99 Cr ₹63.07 Lakh
Total Income ₹681.77 Cr ₹633.59 Cr ₹629.2 Cr ₹554.05 Cr ₹488.13 Cr ₹509.8 Cr ₹360.13 Cr
Cost of Materials Consumed ₹431.18 Cr ₹401 Cr ₹394.85 Cr ₹321.61 Cr ₹297.33 Cr ₹265.45 Cr ₹223.06 Cr
Purchases of Stock-in-Trade ₹3.74 Cr ₹9.66 Cr ₹6.03 Cr ₹24.34 Cr ₹3.23 Cr ₹20.82 Cr ₹9.78 Cr
Changes in Inventories ₹4.1 Cr -₹6.04 Cr ₹1.06 Cr ₹12.62 Cr -₹29.19 Cr ₹15.52 Cr -₹22.81 Cr
Employee Benefit Expense ₹65.21 Cr ₹60.54 Cr ₹52.28 Cr ₹49.95 Cr ₹43.27 Cr ₹37.16 Cr ₹36.85 Cr
Finance Costs ₹10.47 Cr ₹9.34 Cr ₹8.59 Cr ₹6.08 Cr ₹5.12 Cr ₹6.24 Cr ₹8.91 Cr
Depreciation & Amortisation ₹17.47 Cr ₹15.59 Cr ₹12.89 Cr ₹12.71 Cr ₹11.1 Cr ₹10.19 Cr ₹9.58 Cr
Other Expenses ₹115.24 Cr ₹91.55 Cr ₹85.95 Cr ₹90.68 Cr ₹75.48 Cr ₹71.08 Cr ₹65.93 Cr
Total Expenses ₹647.41 Cr ₹581.64 Cr ₹561.66 Cr ₹517.99 Cr ₹406.35 Cr ₹426.46 Cr ₹331.29 Cr
Profit Before Exceptional Items & Tax ₹34.36 Cr ₹51.95 Cr ₹67.54 Cr ₹36.07 Cr ₹81.78 Cr ₹83.34 Cr ₹28.84 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 -₹55.42 Lakh
Profit Before Tax ₹34.36 Cr ₹51.95 Cr ₹67.54 Cr ₹36.07 Cr ₹81.78 Cr ₹83.34 Cr ₹28.28 Cr
Total Tax Expense ₹8.63 Cr ₹13.4 Cr ₹16.59 Cr ₹8.83 Cr ₹20.75 Cr ₹21.73 Cr ₹7.26 Cr
Net Profit ₹25.73 Cr ₹38.55 Cr ₹50.96 Cr ₹27.23 Cr ₹61.03 Cr ₹61.61 Cr ₹21.02 Cr
  attributable to Owners ₹0 ₹38.55 Cr ₹20.61 Lakh ₹27.23 Cr ₹61.03 Cr ₹61.61 Cr ₹21.02 Cr
  attributable to NCI ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income ₹51.85 Lakh -₹79.49 Lakh ₹20.61 Lakh ₹30.71 Lakh ₹11.96 Lakh ₹22.77 Lakh ₹18.43 Lakh
Total Comprehensive Income ₹26.25 Cr ₹37.76 Cr ₹51.16 Cr ₹27.54 Cr ₹61.15 Cr ₹61.83 Cr ₹21.2 Cr
EBITDA (computed) ₹62.3 Cr ₹76.88 Cr ₹89.02 Cr ₹54.86 Cr ₹98 Cr ₹99.77 Cr ₹47.33 Cr
Basic EPS ₹5.33 ₹7.99 ₹10.57 ₹5.65 ₹13.77 ₹14.24 ₹4.86
Diluted EPS ₹5.33 ₹7.99 ₹10.55 ₹5.65 ₹13.77 ₹14.24 ₹4.86
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹908.36 Cr ₹844.01 Cr ₹743.25 Cr ₹649.7 Cr
Non-current Assets ₹385.19 Cr ₹334.26 Cr ₹289.22 Cr ₹250.63 Cr
Current Assets ₹523.18 Cr ₹509.75 Cr ₹454.03 Cr ₹399.07 Cr
Property, Plant & Equipment ₹337.05 Cr ₹196.65 Cr ₹179.04 Cr ₹162.82 Cr
Inventories ₹164.21 Cr ₹169.42 Cr ₹138.49 Cr ₹130.61 Cr
Trade Receivables ₹262.66 Cr ₹214.93 Cr ₹212.33 Cr ₹162.56 Cr
Cash & Equivalents ₹68.2 Lakh ₹19.47 Cr ₹8.09 Cr ₹7.4 Cr
Equity (Net Worth) ₹530.28 Cr ₹518.35 Cr ₹491.25 Cr ₹439.25 Cr
Equity Share Capital ₹48.29 Cr ₹48.29 Cr ₹48.21 Cr ₹48.21 Cr
Borrowings (Non-current) ₹13.95 Cr ₹16.48 Cr ₹16.6 Cr ₹17.89 Cr
Borrowings (Current) ₹138.74 Cr ₹131.3 Cr ₹82.63 Cr ₹57.35 Cr
Total Debt (computed) ₹152.69 Cr ₹147.79 Cr ₹99.23 Cr ₹75.24 Cr
Current Liabilities ₹346.18 Cr ₹252.34 Cr ₹218.53 Cr ₹176.97 Cr
Total Liabilities ₹378.08 Cr ₹325.66 Cr ₹252 Cr ₹210.45 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹66.75 Cr ₹41.87 Cr ₹43.22 Cr ₹34.02 Cr -₹33.53 Cr
Investing Cash Flow -₹64.6 Cr -₹56.43 Cr -₹43.55 Cr -₹12.65 Cr -₹84.42 Cr
Financing Cash Flow -₹20.94 Cr ₹25.87 Cr ₹98.85 Lakh -₹19.84 Cr ₹122.82 Cr
Capital Expenditure ₹58.48 Cr ₹54.9 Cr ₹50.15 Cr ₹54.9 Cr ₹39.59 Cr
Free Cash Flow (computed) ₹8.27 Cr -₹13.03 Cr -₹6.93 Cr -₹20.87 Cr -₹73.12 Cr
Dividends Paid ₹14.49 Cr ₹0 ₹14.46 Cr ₹14.46 Cr ₹6.49 Cr
Net Change in Cash -₹18.79 Cr ₹11.38 Cr ₹69.49 Lakh ₹1.53 Cr ₹4.93 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹234.02 Cr ₹194.28 Cr ₹117.91 Cr ₹135.22 Cr ₹172.36 Cr ₹166.24 Cr ₹151.56 Cr ₹139.44 Cr ₹186.08 Cr ₹158.92 Cr ₹152.59 Cr ₹117 Cr
Other Income ₹9.04 Lakh ₹6.79 Lakh ₹2.56 Lakh ₹2.56 Cr ₹3.26 Cr ₹17.17 Lakh ₹99.5 Lakh ₹2.63 Cr ₹9.67 Cr ₹2.43 Cr ₹13.02 Lakh ₹5.64 Lakh
Total Income ₹234.11 Cr ₹194.35 Cr ₹117.93 Cr ₹137.77 Cr ₹175.62 Cr ₹166.41 Cr ₹152.56 Cr ₹142.06 Cr ₹195.75 Cr ₹161.35 Cr ₹152.72 Cr ₹117.06 Cr
Cost of Materials Consumed ₹139.93 Cr ₹117.87 Cr ₹93.08 Cr ₹80.3 Cr ₹109.2 Cr ₹96.75 Cr ₹103.54 Cr ₹91.51 Cr ₹108.94 Cr ₹108.91 Cr ₹109.91 Cr ₹69.95 Cr
Purchases of Stock-in-Trade ₹1.84 Cr ₹1.23 Cr ₹28.02 Lakh ₹38.87 Lakh ₹7.77 Cr ₹41.64 Lakh ₹98.73 Lakh ₹48.73 Lakh ₹4.21 Cr -₹2.26 Cr ₹93.39 Lakh ₹27.4 Lakh
Changes in Inventories ₹4.78 Cr ₹11.96 Cr -₹17.35 Cr ₹4.71 Cr -₹1.6 Cr ₹8.54 Cr -₹6.88 Cr -₹6.1 Cr ₹14.65 Cr -₹7.03 Cr -₹16.64 Cr ₹10.08 Cr
Employee Benefit Expense ₹16.46 Cr ₹16.57 Cr ₹16.76 Cr ₹15.43 Cr ₹17.26 Cr ₹15.4 Cr ₹14.53 Cr ₹13.35 Cr ₹12.92 Cr ₹13.74 Cr ₹13.03 Cr ₹12.59 Cr
Finance Costs ₹3.17 Cr ₹2.67 Cr ₹2.09 Cr ₹2.54 Cr ₹2.77 Cr ₹2.16 Cr ₹2.23 Cr ₹2.18 Cr ₹2.59 Cr ₹2.24 Cr ₹1.94 Cr ₹1.83 Cr
Depreciation & Amortisation ₹4.52 Cr ₹4.42 Cr ₹4.28 Cr ₹4.26 Cr ₹3.87 Cr ₹4 Cr ₹3.85 Cr ₹3.87 Cr ₹3.59 Cr ₹3.27 Cr ₹2.77 Cr ₹3.26 Cr
Other Expenses ₹38.07 Cr ₹28.9 Cr ₹30.42 Cr ₹20.25 Cr ₹22.65 Cr ₹25.3 Cr ₹24.64 Cr ₹22.03 Cr ₹23.66 Cr ₹21.97 Cr ₹22.53 Cr ₹15.47 Cr
Total Expenses ₹208.76 Cr ₹183.6 Cr ₹129.56 Cr ₹127.88 Cr ₹161.91 Cr ₹152.56 Cr ₹142.91 Cr ₹127.33 Cr ₹170.57 Cr ₹140.84 Cr ₹134.47 Cr ₹113.45 Cr
Profit Before Exceptional Items & Tax ₹25.35 Cr ₹10.74 Cr -₹11.63 Cr ₹9.89 Cr ₹13.71 Cr ₹13.86 Cr ₹9.64 Cr ₹14.73 Cr ₹25.18 Cr ₹20.51 Cr ₹18.25 Cr ₹3.61 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹25.35 Cr ₹10.74 Cr -₹11.63 Cr ₹9.89 Cr ₹13.71 Cr ₹13.86 Cr ₹9.64 Cr ₹14.73 Cr ₹25.18 Cr ₹20.51 Cr ₹18.25 Cr ₹3.61 Cr
Total Tax Expense ₹6.48 Cr ₹1.4 Cr -₹1.7 Cr ₹2.44 Cr ₹4.03 Cr ₹3.46 Cr ₹2.26 Cr ₹3.64 Cr ₹6.56 Cr ₹4.71 Cr ₹4.48 Cr ₹83.68 Lakh
Net Profit ₹18.87 Cr ₹9.34 Cr -₹9.92 Cr ₹7.45 Cr ₹9.68 Cr ₹10.4 Cr ₹7.38 Cr ₹11.1 Cr ₹18.62 Cr ₹15.79 Cr ₹13.77 Cr ₹2.77 Cr
  attributable to Owners ₹0 ₹9.34 Cr - ₹7.45 Cr ₹9.68 Cr ₹10.4 Cr ₹7.38 Cr ₹11.1 Cr ₹5.89 Lakh ₹15.79 Cr ₹13.77 Cr ₹2.77 Cr
  attributable to NCI ₹0 ₹0 - ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income ₹1.05 Cr -₹18.89 Lakh -₹10.73 Lakh -₹23.25 Lakh -₹99.72 Lakh ₹11.45 Lakh ₹4.18 Lakh ₹4.6 Lakh ₹5.89 Lakh ₹4.64 Lakh ₹6.22 Lakh ₹3.86 Lakh
Total Comprehensive Income ₹19.91 Cr ₹9.15 Cr -₹10.03 Cr ₹7.22 Cr ₹8.68 Cr ₹10.51 Cr ₹7.43 Cr ₹11.14 Cr ₹18.68 Cr ₹15.84 Cr ₹13.83 Cr ₹2.81 Cr
EBITDA (computed) ₹33.04 Cr ₹17.83 Cr -₹5.25 Cr ₹16.69 Cr ₹20.35 Cr ₹20.01 Cr ₹15.73 Cr ₹20.79 Cr ₹31.36 Cr ₹26.01 Cr ₹22.96 Cr ₹8.7 Cr
Basic EPS ₹3.91 ₹1.93 ₹-2.06 ₹1.54 ₹2.01 ₹0.00 ₹1.53 ₹2.30 ₹3.86 ₹3.28 ₹2.86 ₹0.58
Diluted EPS ₹3.91 ₹1.93 ₹-2.06 ₹1.54 ₹2.01 ₹0.00 ₹1.53 ₹2.30 ₹3.85 ₹3.27 ₹2.85 ₹0.58
Latest 12 quarters shown of 25 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Revenue from Operations ₹305.65 Cr ₹271.01 Cr ₹337.46 Cr ₹273.09 Cr ₹204.52 Cr
Other Income ₹2 Cr ₹5.9 Cr ₹16.71 Cr ₹16.09 Cr ₹8.03 Cr
Total Income ₹307.65 Cr ₹276.91 Cr ₹354.17 Cr ₹289.18 Cr ₹212.55 Cr
Cost of Materials Consumed ₹162.87 Cr ₹153.63 Cr ₹217.54 Cr ₹137.41 Cr ₹128.52 Cr
Purchases of Stock-in-Trade ₹3.47 Cr ₹5.59 Cr ₹14.36 Cr ₹36.73 Cr ₹3.23 Cr
Changes in Inventories ₹3.79 Cr -₹1.84 Cr -₹1.74 Cr ₹3.55 Cr -₹3.93 Cr
Employee Benefit Expense ₹32.94 Cr ₹30.02 Cr ₹25.61 Cr ₹25.15 Cr ₹21.05 Cr
Finance Costs ₹4.2 Cr ₹3.77 Cr ₹4.5 Cr ₹2.67 Cr ₹2.95 Cr
Depreciation & Amortisation ₹4.98 Cr ₹5 Cr ₹4.62 Cr ₹4.41 Cr ₹4.32 Cr
Other Expenses ₹54.99 Cr ₹44.96 Cr ₹44.77 Cr ₹42.34 Cr ₹40.23 Cr
Total Expenses ₹267.25 Cr ₹241.12 Cr ₹309.65 Cr ₹252.27 Cr ₹196.38 Cr
Profit Before Exceptional Items & Tax ₹40.39 Cr ₹35.79 Cr ₹44.52 Cr ₹36.92 Cr ₹16.16 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹40.39 Cr ₹35.79 Cr ₹44.52 Cr ₹36.92 Cr ₹16.16 Cr
Total Tax Expense ₹9.99 Cr ₹8.94 Cr ₹9.88 Cr ₹5.66 Cr ₹4.42 Cr
Net Profit ₹30.4 Cr ₹26.86 Cr ₹34.64 Cr ₹31.25 Cr ₹11.74 Cr
Other Comprehensive Income ₹31.06 Lakh -₹46.65 Lakh ₹7.59 Lakh ₹7.26 Lakh ₹13.75 Lakh
Total Comprehensive Income ₹30.71 Cr ₹26.39 Cr ₹34.71 Cr ₹31.33 Cr ₹11.88 Cr
EBITDA (computed) ₹49.57 Cr ₹44.56 Cr ₹53.64 Cr ₹44 Cr ₹23.44 Cr
Basic EPS ₹6.30 ₹5.57 ₹7.18 ₹6.48 ₹2.65
Diluted EPS ₹6.30 ₹5.57 ₹7.17 ₹6.48 ₹2.65
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹605.89 Cr ₹546.48 Cr ₹510.88 Cr ₹505.95 Cr
Non-current Assets ₹365.65 Cr ₹337.44 Cr ₹323.17 Cr ₹315.54 Cr
Current Assets ₹240.24 Cr ₹209.05 Cr ₹187.7 Cr ₹190.41 Cr
Property, Plant & Equipment ₹81.7 Cr ₹61.2 Cr ₹51.13 Cr ₹45.82 Cr
Inventories ₹65.85 Cr ₹55.75 Cr ₹49.49 Cr ₹47.6 Cr
Trade Receivables ₹132.58 Cr ₹91.92 Cr ₹87.8 Cr ₹83.81 Cr
Cash & Equivalents ₹22.34 Lakh ₹19.18 Cr ₹5.65 Cr ₹1.04 Cr
Equity (Net Worth) ₹447.83 Cr ₹431.44 Cr ₹416.87 Cr ₹395.59 Cr
Equity Share Capital ₹48.29 Cr ₹48.29 Cr ₹48.21 Cr ₹48.21 Cr
Borrowings (Non-current) ₹3.11 Cr ₹3.56 Cr ₹2.23 Cr ₹2.3 Cr
Borrowings (Current) ₹43.24 Cr ₹41.75 Cr ₹20.49 Cr ₹25.58 Cr
Total Debt (computed) ₹46.36 Cr ₹45.31 Cr ₹22.71 Cr ₹27.88 Cr
Current Liabilities ₹146.94 Cr ₹103.33 Cr ₹84.54 Cr ₹100.88 Cr
Total Liabilities ₹158.06 Cr ₹115.05 Cr ₹94.01 Cr ₹110.36 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹29.66 Cr ₹23.3 Cr ₹34.96 Cr ₹16.87 Cr -₹37.81 Cr
Investing Cash Flow -₹30.08 Cr -₹15.41 Cr -₹6.27 Cr ₹10.05 Cr -₹100.26 Cr
Financing Cash Flow -₹18.53 Cr ₹5.64 Cr -₹24.08 Cr -₹26.13 Cr ₹138 Cr
Capital Expenditure ₹23.45 Cr ₹16.55 Cr ₹9.29 Cr ₹5.54 Cr ₹3.13 Cr
Free Cash Flow (computed) ₹6.21 Cr ₹6.75 Cr ₹25.67 Cr ₹11.32 Cr -₹40.94 Cr
Dividends Paid ₹14.49 Cr ₹14.46 Cr ₹14.46 Cr ₹14.46 Cr ₹6.49 Cr
Net Change in Cash -₹18.95 Cr ₹13.53 Cr ₹4.61 Cr ₹78.57 Lakh -₹7.31 Lakh
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹118.04 Cr ₹93.88 Cr ₹42.39 Cr ₹51.33 Cr ₹75.94 Cr ₹71.94 Cr ₹73.53 Cr ₹49.61 Cr ₹90.62 Cr ₹82.33 Cr ₹98.64 Cr ₹65.86 Cr
Other Income ₹1 Cr ₹32.03 Lakh ₹32.33 Lakh ₹1.8 Cr ₹1.92 Cr ₹74.56 Lakh ₹1.12 Cr ₹2.12 Cr ₹8.15 Cr ₹1.29 Cr ₹5.79 Cr ₹17.72 Lakh
Total Income ₹119.04 Cr ₹94.2 Cr ₹42.71 Cr ₹53.13 Cr ₹77.85 Cr ₹72.68 Cr ₹74.65 Cr ₹51.73 Cr ₹98.77 Cr ₹83.62 Cr ₹104.43 Cr ₹66.04 Cr
Cost of Materials Consumed ₹58.28 Cr ₹51.05 Cr ₹26.19 Cr ₹27.36 Cr ₹43.88 Cr ₹36.01 Cr ₹41.91 Cr ₹31.84 Cr ₹56.74 Cr ₹48.04 Cr ₹71.41 Cr ₹41.35 Cr
Purchases of Stock-in-Trade ₹1.58 Cr ₹1.23 Cr ₹28.02 Lakh ₹38.87 Lakh ₹2.63 Cr ₹41.64 Lakh ₹1.32 Cr ₹1.22 Cr ₹1.35 Cr ₹61.06 Lakh ₹4.04 Cr ₹8.35 Cr
Changes in Inventories ₹4.37 Cr ₹47.31 Lakh -₹2.98 Cr ₹1.92 Cr -₹2.75 Cr ₹5.79 Cr ₹25.16 Lakh -₹5.13 Cr -₹1.12 Cr ₹2.52 Cr -₹3.3 Cr ₹17.57 Lakh
Employee Benefit Expense ₹8.36 Cr ₹8.41 Cr ₹8.83 Cr ₹7.35 Cr ₹8.86 Cr ₹7.41 Cr ₹7.39 Cr ₹6.36 Cr ₹6.35 Cr ₹6.77 Cr ₹6.13 Cr ₹6.36 Cr
Finance Costs ₹1.17 Cr ₹1.16 Cr ₹82.54 Lakh ₹1.04 Cr ₹1.26 Cr ₹98.57 Lakh ₹83.14 Lakh ₹69.15 Lakh ₹1.78 Cr ₹1.02 Cr ₹74.47 Lakh ₹95.24 Lakh
Depreciation & Amortisation ₹1.34 Cr ₹1.25 Cr ₹1.16 Cr ₹1.22 Cr ₹1.24 Cr ₹1.33 Cr ₹1.23 Cr ₹1.2 Cr ₹1.16 Cr ₹1.17 Cr ₹1.16 Cr ₹1.12 Cr
Other Expenses ₹18.87 Cr ₹15.05 Cr ₹13.28 Cr ₹9.24 Cr ₹11.03 Cr ₹10.91 Cr ₹12.98 Cr ₹10.04 Cr ₹11.97 Cr ₹12.34 Cr ₹11.67 Cr ₹7.49 Cr
Total Expenses ₹93.97 Cr ₹78.62 Cr ₹47.58 Cr ₹48.52 Cr ₹66.14 Cr ₹62.86 Cr ₹65.9 Cr ₹46.21 Cr ₹78.22 Cr ₹72.47 Cr ₹91.84 Cr ₹65.81 Cr
Profit Before Exceptional Items & Tax ₹25.07 Cr ₹15.58 Cr -₹4.87 Cr ₹4.61 Cr ₹11.71 Cr ₹9.83 Cr ₹8.75 Cr ₹5.51 Cr ₹20.55 Cr ₹11.16 Cr ₹12.58 Cr ₹22.5 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹25.07 Cr ₹15.58 Cr -₹4.87 Cr ₹4.61 Cr ₹11.71 Cr ₹9.83 Cr ₹8.75 Cr ₹5.51 Cr ₹20.55 Cr ₹11.16 Cr ₹12.58 Cr ₹22.5 Lakh
Total Tax Expense ₹6.33 Cr ₹3.45 Cr -₹87.75 Lakh ₹1.09 Cr ₹3.11 Cr ₹2.42 Cr ₹2.14 Cr ₹1.27 Cr ₹5.24 Cr ₹2.65 Cr ₹1.92 Cr ₹7.16 Lakh
Net Profit ₹18.74 Cr ₹12.13 Cr -₹3.99 Cr ₹3.52 Cr ₹8.6 Cr ₹7.41 Cr ₹6.6 Cr ₹4.25 Cr ₹15.31 Cr ₹8.51 Cr ₹10.66 Cr ₹15.34 Lakh
Other Comprehensive Income ₹66.06 Lakh -₹11.67 Lakh -₹11.66 Lakh -₹11.67 Lakh -₹52.39 Lakh ₹1.9 Lakh ₹1.94 Lakh ₹1.9 Lakh ₹1.99 Lakh ₹1.87 Lakh ₹1.86 Lakh ₹1.87 Lakh
Total Comprehensive Income ₹19.4 Cr ₹12.01 Cr -₹4.11 Cr ₹3.4 Cr ₹8.08 Cr ₹7.43 Cr ₹6.62 Cr ₹4.26 Cr ₹15.33 Cr ₹8.53 Cr ₹10.68 Cr ₹17.21 Lakh
EBITDA (computed) ₹27.59 Cr ₹18 Cr -₹2.88 Cr ₹6.87 Cr ₹14.21 Cr ₹12.15 Cr ₹10.81 Cr ₹7.4 Cr ₹23.49 Cr ₹13.35 Cr ₹14.49 Cr ₹2.3 Cr
Basic EPS ₹3.88 ₹2.51 ₹-0.83 ₹0.73 ₹1.78 ₹1.54 ₹1.37 ₹0.88 ₹3.18 ₹1.77 ₹2.21 ₹0.03
Diluted EPS ₹3.88 ₹2.51 ₹-0.83 ₹0.73 ₹1.78 ₹1.53 ₹1.37 ₹0.87 ₹3.17 ₹1.76 ₹2.20 ₹0.03
Latest 12 quarters shown of 22 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Kopran Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Kopran Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 44.42%, foreign institutional investors hold 0.57%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 55.00% of Kopran Limited. The company had 58,639 shareholders on record.

Promoters: 44.42%FII (Foreign Institutional): 0.57%Retail & Others: 55.00%
Mar 2026
QUARTER
44.42% Promoters
0.57% FII (Foreign Institutional)
55.00% Retail & Others
Promoter holding - history
Now 44.42% · Mar 2026High 44.95% · Mar 2016Low 42.07% · Dec 2015
41%42.3%43.5%44.8%46%Dec 2015Jun 2018Dec 2020Mar 2023Sep 2025Dec 2015: 42.07%Mar 2016: 44.95%Jun 2016: 44.95%Sep 2016: 44.95%Dec 2016: 44.95%Mar 2017: 44.95%Jun 2017: 44.95%Sep 2017: 44.95%Dec 2017: 43.65%Mar 2018: 43.78%Jun 2018: 43.78%Sep 2018: 43.78%Dec 2018: 43.78%Mar 2019: 43.78%Jun 2019: 43.78%Sep 2019: 43.78%Dec 2019: 43.77%Mar 2020: 43.77%Jun 2020: 43.78%Sep 2020: 43.78%Dec 2020: 43.78%Mar 2021: 43.78%Jun 2021: 43.78%Sep 2021: 43.78%Dec 2021: 43.78%Jan 2022: 44.25%Mar 2022: 44.25%Jun 2022: 44.25%Sep 2022: 44.25%Dec 2022: 44.30%Mar 2023: 44.30%Jun 2023: 44.49%Sep 2023: 44.49%Dec 2023: 44.49%Mar 2024: 44.49%Jun 2024: 44.49%Sep 2024: 44.49%Dec 2024: 44.46%Mar 2025: 44.42%Jun 2025: 44.42%Sep 2025: 44.42%Dec 2025: 44.42%Mar 2026: 44.42%44.95%42.07%44.42%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters44.42%44.42%44.42%44.42%44.42%44.46%
Public55.58%55.58%55.58%55.58%55.58%55.54%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters44.42%44.42%44.49%44.30%44.25%43.78%43.77%43.78%43.78%44.95%44.95%
Public55.58%55.58%55.51%55.70%55.75%56.22%56.23%56.22%56.22%55.05%55.05%
Promoter change (YoY, %pts)+0.00-0.07+0.19+0.05+0.47+0.01-0.01+0.00-1.17+0.00-

Board & Governance of Kopran Limited

As per the corporate governance filing with NSE for the quarter ended 31-DEC-2025, the board of Kopran Limited has 6 directors - 3 independent and 1 executive. The board is chaired by Surendra Somani.

DirectorPositionOn board sinceListed boards
Surendra Somani Executive Director · Chairperson 1977-06-11 1
Adarsh Rajendra Somani Non-Executive - Non Independent Director 2018-05-29 2
Mamta Ashok Biyani Non-Executive - Independent Director 2019-05-08 3
Narayan Tulsiram Atal Non-Executive - Independent Director 2019-05-08 3
Varun Somani Non-Executive - Non Independent Director 2018-05-29 3
Chandresh Gunvant Gandhi Non-Executive - Independent Director 2025-07-29 2
Board Committees
CommitteeMembers
Audit Committee Narayan Tulsiram Atal (Chairperson), Chandresh Gunvant Gandhi, Mamta Ashok Biyani, Surendra Somani
Nomination and remuneration committee Chandresh Gunvant Gandhi (Chairperson), Mamta Ashok Biyani, Varun Somani
Stakeholders Relationship Committee Varun Somani (Chairperson), Adarsh Rajendra Somani, Chandresh Gunvant Gandhi
Risk Management Committee Adarsh Rajendra Somani (Chairperson), Varun Somani, Mamta Biyani
Corporate Social Responsibility Committee Mamta Ashok Biyani (Chairperson), Varun Somani, Surendra Somani
Corporate Affairs Committee Surendra Somani (Chairperson), Varun Somani, Adarsh Rajendra Somani

Group Structure of Kopran Limited

Kopran Limited has 2 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Kopran Limited's business expansion strategy and organizational complexity.

2
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Kopran Research Laboratories Limited U24230MH1986PLC040601 -
Kopran Lifesciences Limited U74120MH2010PLC211125 -

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Kopran Limited

Open charges
₹856.35 Cr
Satisfied charges
₹727.36 Cr
Breakdown by lending institutions
State Bank of India₹370.65 Cr
Import Export Bank of India₹300.00 Cr
Sbicap Trustee Company Limited₹69.25 Cr
Export-Import Banbk of India₹15.00 Cr
The Industrail Credit and Investment Corporation of Indai Lt₹10.00 Cr
Others₹91.45 Cr
Latest charge details
DateLenderAmountStatus
30 Jul 2020 State Bank of India ₹124.75 Cr Open
26 Dec 2014 State Bank of India ₹3.5 Cr Open
28 Jan 2013 State Bank of India ₹11.5 Cr Open
04 Jul 2007 Canara Bank ₹8 Cr Open
10 Aug 2005 State Bank of India ₹2.6 Cr Open

Total charge records: 108 View all charges

Employees and EPFO Compliance at Kopran Limited

Kopran Limited has a workforce of 363 employees as of Apr 02, 2024.

Employee count
363
Active EPFO establishments
1
Employee growth
-11.46%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Kopran Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Kopran Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Kopran Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Kopran Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Kopran Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Kopran Limited

MSME Payment Delays by Kopran Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Kopran Limited

Subsidiaries & Group Companies of Kopran Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Kopran Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Kopran Limited

MCA Filings & Documents of Kopran Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Kopran Limited

Charges
14 Oct 2025
A charge registered on 25 Jun 2025 via Charge ID 101120075 with Others was fully satisfied on 14 Oct 2025.
Charges
14 Oct 2025
A charge registered on 14 Feb 1995 via Charge ID 90222441 with Union Bank Of India was fully satisfied on 14 Oct 2025.
Charges
14 Oct 2025
A charge registered on 20 Jan 1993 via Charge ID 90222138 with Union Bank Of India was fully satisfied on 14 Oct 2025.
Charges
14 Oct 2025
A charge registered on 30 Jan 1992 via Charge ID 90222017 with Union Bank Of India was fully satisfied on 14 Oct 2025.
Charges
14 Oct 2025
A charge registered on 03 Apr 1990 via Charge ID 90221746 with Union Bank Of India was fully satisfied on 14 Oct 2025.
Charges
14 Oct 2025
A charge registered on 26 Jun 1989 via Charge ID 90221621 with Union Bank Of India was fully satisfied on 14 Oct 2025.

Recent News on Kopran Limited

Change in Secretarial Auditors of Kopran
09 May 2019 · Business Standard

Frequently Asked Questions about Kopran Limited

Kopran Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 26 April 1958 (68+ years old) and is registered under CIN L24230MH1958PLC011078. Listed on BSE: 524280 and NSE: KOPRAN. The company has 363 employees.

Kopran Limited reported revenue of ₹629.2 Cr for FY 2024 (up 14.00% YoY).

The current directors of Kopran Limited are:

The primary industry of Kopran Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Kopran Limited is listed on both BSE (code: 524280) and NSE (symbol: KOPRAN).

Kopran Limited can be reached at the registered office: Parijat House1076 Dr E Moses Road Worli Mumbai – 18, Maharashtra, India – 400018, or through the website kopran.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available